STAMFORD, Conn. and PITTSBURGH, Penn., September 5, 2018 – Purdue Pharma L.P. (Purdue) and Harm Reduction Therapeutics, Inc. today announced that Purdue is providing a $3.42 million grant to Harm Reduction Therapeutics to advance the...
News and Media Prescription Drug Safety Curriculum Increased Student Knowledge by 49 Percent in its Inaugural Academic Year Purdue Expands Established Commitment to Include a Statewide Education Program in Collaboration with EVERFI and Connecticut Prevention...
STAMFORD, Conn. – February 9, 2018 – Purdue Pharma L.P. issued the following statement today: We have restructured and significantly reduced our commercial operation and our sales representatives will no longer promote opioids to prescribers. Going...
Research includes study of Virtual Reality technology as potential tool in chronic pain assessment STAMFORD, Conn. – January 31, 2018 – Purdue Pharma L.P. today announced the funding of three grants for investigator-initiated research on developing...
Please read carefully the Purdue Pharma L.P. Privacy Policy (the “Privacy Policy”), which is part of the Purdue Pharma L.P. Terms and Conditions, before you access, download, or otherwise use any of our websites, related other parties’ websites, mobile applications, or any electronic service (collectively, the “Service”). This Privacy Policy describes the information collected through Your use of the Service, how we use it, how we share it, how we protect it, and the choices You can make about Your information.
